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ABSTRACT 
 
Background: The World Health Organization predicts that the deaths related to Non-
Communicable Diseases in Africa will rise by 27% over the next decade. As a 
response to the problem, the National Department of Health in South Africa 
 v
introduced interventions that focussed on implementing health facility based Non-
Communicable Diseases register and a monitoring tool. The Gauteng Department of 
Health in South Africa started introducing the monitoring tool in public health 
facilities since April 2011 in a phased manner. This study used a one week data 
collected in the month of April 2011 in selected health facilities within the 
Johannesburg Health District. 
 
Aim: To describe the socio-demographic and clinical profiles of the study population 
attending the health facilities in Johannesburg Health District. 
 
Methodology: A cross-sectional study design was used for the study. The data was 
collected from the selected Community Health Centres using the monitoring tool 
developed by the National Department of Health. The data were collected for a 
week from randomly selected health facilities in 2011. 
 
Results: Nine-hundred and sixty eight study participants were recruited from the five 
community health centres for the assessment of non-communicable diseases.  
Among the study participants, the prevalence of hypertension (94.6%) was highest 
followed by diabetes (39.4%) and hyper-cholesterolaemia (4.6%). A number of study 
participants had comorbidity associated with all three conditions. The majority of 
them were 45 years and above (88%), female (53%), and black (98%); There were no 
significant association between these three conditions and risk factors such as 
smoking and alcohol drinking. The complications among the study participants 
include nephropathy, cardiac diseases and retinopathy. Annual screening was done 
for a number of study participants but it was erratically done so that all study 
participants were not screened. Twenty-two percent of 968 study participants have 
blood pressure of more than 140/90mmHg.  Twenty percent of study participants 
have a weight more than 90kg. The sugar level of 22% study participants was more 
than 7mmol/l. 
 
Conclusion: The NCD monitoring tool could be used as an effective tool for 
management of NCD in PHC setting like Johannesburg Health District.   
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GLOSSARY OF TERMS 
Assessment refers to the measure of the extent of something and the degree to 
which action or policy is carried out. 
Hypertension patients for follow-up:  Patients are diagnosed, put on treatment and 
regularly visit the health facility to check compliance and control of the hypertension 
(source: DHIS, 2010) 
Hypertension patients on treatment:  Number of clients initiated on hypertension 
treatment for the first time (source: DHIS, 2010) 
Hypertension patients on register: All patients who have controlled or no controlled 
hypertension put on register or some of records. (source: DHIS, 2010) 
Diabetes patients for follow-up: Patients are diagnosed, put on treatment and 
regularly visit the health facility to check compliance and control of the diabetes 
(source: DHIS, 2010) 
Diabetes patients on treatment: Number of clients initiated on diabetes treatment 
for the first time (source: DHIS, 2010) 
Diabetes patients on register: All patients who have controlled or no controlled 
diabetes put on register or some of records. (source: DHIS, 2010) 
Health district is defined as geographic area that is small enough to allow maximal 
involvement of the community so that local health needs are met, but also large 
enough to effect economies of scale (Department of Health, White paper on 
transformation of Health System in South Africa, 1997). 
Selected NCD is hypertension, diabetes, and hypercholesterolemia 
Co-morbidity refers to simultaneous occurrence of two or more diseases. Example of 
 xii
chronic diseases co-morbidity include: (1) the association between chronic 
obstructive pulmonary disease and cancer. (Source: Chronic diseases and their risks 
factors: a global burden) 
Urban is an area that is characterized by higher population density and vast human 
features in comparison to areas surrounding it. 
LIST OF ABBREVIATIONS 
 
AIDS Acquired Immunodeficiency Syndrome 
BMI Body Mass Index 
CHCs Community Health Centres 
DHIS District Health Information System 
HIV Human Immunodeficiency Virus 
JHB Johannesburg 
ID Identity document 
MDG Millennium Developmental Goals 
NCD Non-Communicable Diseases 
NDoH National Department of Health 
NSDA Negotiated Service Delivery Agreement 
PHC Primary Health Care 
NCSS A statistical analysis and graphics software package that outputs 
graphics from spreadsheet, database, and statistical files for use 
with popular word processors and presentation software. 
SEMDSA The Society for Endocrinology, Metabolism and Diabetes of South 
Africa 
SD Standard deviation 
UN United Nations 
WHO World Health Organisation 
WITS University of the Witwatersrand  
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CHAPTER 1 
INTRODUCTION 
 
The purpose of this study was to assess the selected Non-Communicable Diseases in an 
urban health district of South Africa. This introductory chapter will cover the 
background to the study, statement of the problem, its aims and objectives and an 
outline of subsequent chapters. 
 
1.1 BACKGROUND 
 
During the last decade, non-communicable diseases (NCD) had been getting much 
attention due to increasing prevalence, morbidity and mortality associated with them 
not only in developed but also in developing countries. It is estimated that 58% of all 
deaths worldwide were contributed to NCD in 2008 (Alwan, MacLean, Riley, 2010). 
These diseases are generally regarded as disease of the affluent. The WHO predicts that 
the deaths related to NCD in Africa will rise by 27% over the next decade (Alwan, 2008).  
 
Despite the mortality, morbidity and the burden of the NCD, the conditions had eluded 
the health list of priorities. The NCD did not feature in the MDG of the United Nations.  
However, the situation had changed during last few years. In 2010, the United Nations 
General Assembly passed a resolution on its 86th plenary session for prevention and 
control of non-communicable diseases. The Assembly also unanimously adopted a 
resolution by which it decided to convene a high-level meeting on “Prevention and 
control of non-communicable diseases” in September 2011 due to high prevalence of 
NCD in both developed and developing countries (UNO, 2010).  
 
The South African Minister of Health also highlighted the challenges associated with 
high burden of NCD in South Africa at the First Global Conference on Healthy Lifestyles 
and NCD Control held in Moscow in 2011 (Department of Health, 2011). Recently, the 
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NCD cluster within the National Department of Health had introduced a number of 
measures for prevention and control of NCD as well as collected accurate information 
about the burden of NCD in South Africa. This included a NCD register for keeping 
records of NCD patients at the clinic as well as a NCD monitoring tool called NCD 
passport (Appendix B) to record individual patient details. 
 
1.2 JUSTIFICATION FOR THE STUDY 
 
The Gauteng Province has one of the highest burdens of NCD in the country (Gauteng 
Department of Health, 2008). Therefore, the Gauteng Department of Health has decided 
to monitor closely the prevalence and the clinical management of NCD through its five 
districts (namely Ekurhuleni, Johannesburg, Sedibeng, Tshwane and West Rand). As a 
part of that process, the district offices are expected to monitor routinely the DHIS data 
on NCD, which were not often done optimally. In addition, the districts were asked to 
introduce the NCD register and NCD passport (a monitoring tool) as disease 
management tools in the public health facilities. The study sought to describe the socio-
demographic and clinical profiles of the patients attending the health facilities in 
Johannesburg Health District. The three selected NCD (Hypertension, Diabetes and 
Hypercholesterolemia) were chosen based on their common etio-pathology. They are 
also the commonest conditions seen in the public health facilities in South Africa.   
 
The findings from this study would hopefully assist the District Management Team to 
understand the burden of the NCD and the associated clinical management of these 
diseases in the District. 
 
1.3 RESEARCH QUESTION 
 
What are the socio-demographic and clinical profiles of study participants with selected 
NCD attending the health facilities in the Johannesburg Health District? 
 
 - 3 - 
1.4 STUDY OBJECTIVES 
 
1.4.1 BROAD OBJECTIVE 
 
To describe the socio-demographic and clinical profiles of study participants with 
selected NCD attending public health facilities in the Johannesburg Health District during 
the one week period in 2011. 
 
1.4.2 SPECIFIC OBJECTIVES 
 
1. To describe the socio-demographic profile (age, gender and ethnicity) of study 
participants with selected NCD (Diabetes, Hypertension and 
hypercholesterolemia) during one week study period. 
2. To describe the clinical profile (such as type of diseases) of the same study 
participants. 
 
1.5 FOLLOWING CHAPTERS 
 
The background to the research has been outlined and discussed. Subsequently, 
research question and objectives were defined in this first chapter. A brief outline of the 
following chapters is described below.  
 
Chapter Two: Literature Review: The purpose of the literature review is to review 
related literature and to discuss concepts related to socio-demographic and clinical 
profiles of study participants with NCD. 
 
Chapter Three: Research Methodology: The chapter describes the research 
methodology, study design, setting and scope and data management techniques used in 
this study. 
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Chapter Four: Presentation of Results: This chapter deals with an analysis of the data 
collected for this study relating to its aim and objectives. 
 
Chapter Five: Discussion: The findings from the review of the literature are included in 
this chapter with the results obtained from the analysis in order to address the aims and 
objectives of the study. 
 
Chapter Six: Conclusions and Recommendations: The chapter is the last part of the 
report and derives conclusions from the research related to the objectives of this study, 
makes recommendations and highlights the areas for future research in the field of NCD. 
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CHAPTER 2 
LITERATURE REVIEW 
 
This chapter discusses the appropriate and relevant literature on the socio-demographic 
and clinical profiles of study participants with NCD. In addition to published literature, 
information from various unpublished sources is also reviewed.  
 
2.1 INTRODUCTION 
 
2.1.1 INTERNATIONAL CONTEXT OF NON-COMMUNICABLE DISEASES 
 
In 2008, 58% of all deaths worldwide (approximately 33 million) were related to non-
communicable diseases (Alwan, et al, 2010). The Non-Communicable Disease (NCD) 
more specifically includes cardiovascular disease, diabetes, cancer, and chronic 
respiratory diseases (Abegunde, Mathers, Adam, et al, 2007).  
 
Non-communicable diseases are generally regarded as a disease of the affluent. This 
misconception, is refuted as 80% of total NCD-related deaths occur in low and middle 
income countries (Alwan, et al, 2010). The deaths related to NCD in Africa could rise by 
27% over the next decade (NCD alliance, 2011).The chronicity of NCD results in 
extensive mortality and morbidity. In developing countries, NCD develop at younger 
ages, and result in premature death (Alwan, et al, 2010). The economic burden that 
these diseases impose, on the individual and the health system, cannot be ignored 
(WHO, 2010a).  
 
Despite the mortality and morbidity, and the significant worldwide burden, NCD have 
eluded the public health list of priorities. In 2000, NCD did not feature amongst the eight 
Millennium Development Goals identified by the United Nations. This may have dictated 
the limited funding focussed on it. The Centre for Global Development reported that 
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less than three percent of the US$22 billion spent on health, by international aid 
agencies in lower middle income countries, is spent on NCD (NCD alliance, 2011). 
 
Fortunately, World Leaders in May 2010 resolved to hold a United Nations Summit on 
NCD, which was held in September 2011 in New York. The NCD Alliance Partners have 
taken the lead in ensuring that world leaders commit to specifically identified priorities 
on relevant agenda developed by a participatory effort of stakeholders’ worldwide (NCD 
alliance, 2011). 
 
2.1.2 INTERNATIONAL RECOMMENDED INTERVENTIONS FOR NON-COMMUNICABLE 
DISEASES 
 
In many developing countries the health system is functioning at maximum capacity. A 
worsening epidemic of NCD is set to further impose on an already overwhelmed system 
(Abegunde, et al, 2007). The NCD Alliance, among its many suggestions has highlighted 
the importance of health system strengthening (HSS) with a particular focus on primary 
health care (PHC) addressing the integration of NCD management at this level. The basis 
of successful NCD control relies strongly on effective service approach, health 
promotion and prevention (Puoane, Tsokeli, Sanders, et al, 2008).  
 
NCD have complex aetiologies; social-economic, environmental, cultural, biological 
determinants of health all play a role in the disease development (Figure 2.1). For this 
reason multi-pronged approaches to prevent and alter the modifiable risk factors are 
recommended for interventions (WHO, 2010b) 
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Figure 2.1: Causes of Chronic Diseases 
Source: NCD Alliance, 2011  
 
Disease Control Priorities Project in 2006 listed a set of priority interventions 
identified as cost-effective and affordable to implement in various settings. These 
included supporting and education of populations to increase physical activity, 
improve diets, relevant social marketing and facilitating healthy lifestyle decisions. 
The development of sustainable surveillance systems that monitor weight and 
height, physical activity, and key dietary variables is a key intervention and a focus 
of this study (Jamison, Breman, Measham, et al. 2006).   
 
The WHO STEPwise Framework for NCD Risk Factor Surveillance (Figure 2.2) was 
expected to assist DoH in resource poor settings to identify current and future 
public health needs within the sphere of chronic care. The pinnacle of this 
framework should enhance the essential surveillance of physical and bio-chemical 
measurements in the management of risk factors (Bonita, De Court, Dwyer, 2001).  
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Figure 2.2: World Health Organization STEPwise – Non communicable Diseases Risk 
factors concept 
Source: (Bonita, et al, 2001) 
 
2.2 SOUTH AFRICAN CONTEXT FOR NON-COMMUNICABLE DISEASES 
 
South Africa is contextualised within an epidemiological transition, and endures a 
quadruple burden of disease, with a high prevalence of communicable diseases, 
maternal and child health disorders, injury-related mortality and morbidity and NCD. 
With this in mind, it is not surprising that the importance of NCD prevention and 
management has gone unnoticed (Mayosi, Flisher, Lallo, et al, 2009). This created a 
significant negative on health outcomes in South Africa which was evidenced by data 
from 2004, where one-quarter of all disability-adjusted life years were attributed to 
NCD, more specifically 12% due to cardiovascular diseases, diabetes mellitus, respiratory 
diseases and cancers and in the same year one-fifth of total mortality was related to 
 - 9 - 
NCD (National Department of Health, 2010). 
 
The prevalence of NCD is set to increase, as South Africans continue to adopt sedentary 
lifestyles and unhealthy diets; and the life expectancy of HIV and AIDS patients increases 
with the advent of an enhanced Anti-Retroviral Therapy Programme. For this reason, 
Mayosi et al (2003) in the South African Lancet series have echoed the sentiments of the 
NCD Alliance, by calling for attention into health system strengthening to meet the 
increased demand for good quality chronic care. 
 
2.3 NCD PREVALENCE IN THE JOHANNESBURG HEALTH DISTRICT 
 
The data on diabetes and hypertension is routinely collected from all health facilities in 
the Johannesburg District. Three indicators are routinely collected for diabetes and 
hypertension. The District Health Report for 2011/12 showed that more diabetes follow 
up cases were found in the Sub-district D with the least cases in the Sub-district A. The 
proportion of follow up cases to treatment of cases was better in the Sub-district A than 
the Sub-district D (Johannesburg Heath District, 2012). 
 
Table 2.1 Prevalence of Diabetes Mellitus in 7 Sub-districts in Johannesburg 
   
Totals 
Sub-
district 
A 
 Sub-
district 
B 
Sub-
district 
C 
 Sub-
district 
D 
Sub-
district 
E 
 Sub-
district 
F 
Sub-
district 
G 
Diabetes 
follow-up 183,278 3,871 8,970 7,888 85,242 27,897 21,302 28,108 
Diabetes on 
treatment 13,783 1,684 834 433 3,872 1,217 1,499 4,244 
Diabetes 
patients on 
register 86,373 2,011 5,471 12,329 32,858 177 7,219 26,308 
 
The hypertension follow up cases were found to be more in the Sub-district D (Table 
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2.2). The proportion of follow up cases to treatment was low in most of the sub-districts 
(Johannesburg Heath District, 2012). 
 
Table 2.2 Prevalence of hypertension in 7 Sub-districts in Johannesburg 
  
Totals 
Sub-
district 
A 
 Sub-
district 
B 
Sub-
district 
C 
 Sub-
district 
D 
Sub-
district 
E 
 Sub-
district 
F 
Sub-
district 
G 
Hypertension 
on treatment 23,814 1,744 1,959 1,239 4,757 2,073 3,547 8,495 
Hypertension 
follow-up 672,899 27,107 38,448 39,303 314,232 87,359 66,494 99,956 
Hypertensive 
patients on 
register 334,298 8,632 38,382 60,227 104,661 906 34,781 86,709 
 
2.4 SUPPORTIVE POLICY FRAMEWORKS 
 
With anticipation from the UN Summit on NCD, the political context began to change 
and to target strategies that would have NCD prevention and control as an outcome. 
This is essential as the NCD Alliance advocates that governments become accountable 
and measured on their successes in preventing and managing NCD (NCD Alliance, 2011). 
The National Department of Health (NDoH) Medium Term Strategic Plan 2010/11-
2012/13 among its ten priorities has identified “Mass Mobilisation For Better Health” a 
commitment of the health sector to enhance prevention and management  strategies to 
mitigate the  burden of NCD (National Department of Health, 2010a). Various policies 
and guidelines were introduced in South Africa since 2006 to manage the emergence of 
the NCD within the health system. These policies require that all health facilities in 
South Africa are expected to capture data on the prescribed registers or forms of NCD 
patients and to clinically manage all NCD as per guidelines and procedures outlined from 
the policies. The researcher perceives that the burden of NCD is unknown to many 
health care workers and managers and often the policies with guidelines are not being 
implemented. 
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Subsequently, the Negotiated Service Delivery Agreement (NSDA) within the four output 
areas (namely increasing life expectancy, decreasing maternal and child mortality, 
combating HIV and AIDS and decreasing the burden of disease from tuberculosis and 
strengthening health system effectiveness), has spoken to the focus on NCD prevention 
and management, and increased influx of resources. Improved surveillance of chronic 
diseases are required and the identification of innovative technologies in the sector, 
including recruiting and strengthening the capacity of community health workers’ 
involvement in the implementation of the chronic care model (National Department of 
Health, 2010).  
 
Furthermore, National Guidelines published by the NDoH in 2006 , entitled “Non-
Communicable Diseases Strategic Vision” explains the effective management of NCD 
and the integration all chronic diseases in its treatment in a patient-centred approach 
alignment of a formation of health public policy (National Department of Health, 2006). 
Gauteng Department of Health’s strategy has aligned itself with national priority and 
identified prevention and control NCD (Gauteng Department of Health and Social 
Development, 2009). This strategy included other guidelines as per Table 2.3. 
  
Table 2.3 South African National Guidelines on NCD 
Guidelines 
 
Year 
 
National Guidelines on Primary Prevention of Chronic Diseases of 
Lifestyle 
2005 
 
National Guideline: Non-communicable Diseases: A strategic Vision  
 
2006 
 
South African Hypertension Guideline 
 
2011 
 
South African Dyslipidaemia Guideline 
 
2012 
 
SEMDSA Guideline for Management of Type 2 Diabetes 
 
2012 
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With strong leadership and the much needed political focus on NCD as suggested by the 
NCD Alliance (NCD Alliance, 2011), the time is appropriate to enhance the chronic care 
at the District. The Johannesburg Health District was reported to be experiencing 
challenges in service delivery (one of the six building blocks of the Health System) of in 
the areas of chronic diseases specifically diabetes and hypertension (Smith, 2007). 
 
Hence the development of the Integrated Chronic Disease Map could act as a visual aid 
and comprehensive tool to simplify NCD prevention and management. The tool allows 
for risk factor surveillance of both modifiable risk factors (primary prevention), the 
assurance of appropriate control of biochemical markers (secondary prevention), and 
lastly investigations and monitoring of target organ damage (tertiary prevention) in a 
district setting.  
 
2.5 FACTORS INFLUENCING MANAGEMENT OF NCD 
 
Factors influencing management of NCD can be grouped into three main categories 
namely patient related factors, health professional related factors and health system 
related factors.  
 
2.5.1 PATIENT RELATED FACTORS 
 
Patient related factors such as knowledge, culture and beliefs influences people’s 
attitude to health, as well as their health seeking behaviour and control of NCD 
(Baradaran and Knill-Jones, 2004). Patient factors that influence good management of 
NCD (such as diabetes) include compliance, regular attendance, health education, 
younger age and female (Alberti, Boudriga, Nabli, 2007). Although health education 
plays an important role in improving patients’ compliance, patients are often not 
provided with appropriate health education at the health facilities (Moodley and 
Rambiritch, 2007). 
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2.5.2 HEALTH CARE PROFESSIONAL FACTORS 
 
Better management of NCD is based on the continuous professional development and 
an up to date knowledge of health professionals about the management of NCD 
(Moodley and Rambiritch, 2007). Standardisation of care with the use of clinical 
guidelines has been shown to improve patient outcomes (Brown, Harris, Webster-
Bogaert, et al, 2002).  
 
Thorough clinical examination by health professionals is an essential component for 
management and prevention of complications (Steyn, Levitt, Patel, et al, 2008). 
However this requires time and health professionals often compromise that due to 
increased work load as a result of staff shortages. Other health care professional related 
factors identified included numbers of health care staff, their training, health care 
professional motivation (Sutton, McLean, 2006; Simmons, Lillian, Swan, et al, 2007).  
 
2.5.3 HEALTH SYSTEM FACTORS 
 
The clinical management of NCD requires good organisational systems which provide an 
efficient and effective management of resources such as drug, equipment (Brown, et al, 
2002). The availability of innovative tools such as defaulter tracing and reminder 
systems could assist in achieving better control. Other health system related factors 
found to influence NCD care include the presence of dedicated NCD clinics, availability 
of clinical guidelines, and health (Alberti, et al, 2007).   
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CHAPTER 3 
METHODOLOGY 
 
The methodology for this study was selected on the basis of its aims and objectives. In 
this chapter the following were/would be discussed: setting, scope, and study design 
and research tools. 
 
3.1 STUDY DESIGN 
 
This was a cross sectional study conducted in Johannesburg Health District facilities. 
 
3.2 STUDY SETTING 
 
The study setting was Johannesburg Health District, an urban district, located in 
Gauteng Province of South Africa.  
 
Gauteng Province has five health districts namely Johannesburg, Ekurhuleni, Tshwane, 
Sedibeng and West Rand. The sixth District Metsweding was recently merged with the 
Tshwane District. The Gauteng Department of Health provides health services to 8.3 
million people (uninsured) through a network of hospitals; community health centres 
(CHCs), fixed primary health care (PHC) clinics and mobile clinics, as well as community 
outreach programmes.  
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Figure 3.1 Gauteng Province 
 
Source: Annual Performance plan, 2010/2011-2012/13, Gauteng Department of Health 
 
Johannesburg Health District  
 
The Johannesburg Health District is one of the most populated districts in South Africa. 
Comparing the district with other four districts in the Gauteng Province, it has 114 (36%) 
clinics, 10 (29%) community health centres, one district hospital (9%), one specialised 
hospital, one psychiatric hospital, one (17%) regional hospital, one tertiary hospital 
(33%) and two (50%) central hospitals. All the health facilities provide services for 
patients suffering from NCD. According to Statistics South Africa’s community survey, 
the population served by the public health facilities is estimated at 3,888,180 in 2007 
(Statistics South Africa, 2007). 
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3.3 STUDY SCOPE 
 
The study involved analysis of secondary data collected from selected CHCs using the 
NCD monitoring tool (Appendix B) introduced by the NDoH in 2011. 
 
3.4 STUDY PERIOD 
 
The study period was one week chosen randomly from 52 weeks (without any public 
holiday) in the year 2011.  
 
3.5 STUDY POPULATION AND SAMPLING 
 
The study population included NCD patients attending CHCs in JHB Health District. Five 
CHCs were randomly chosen from a total of seven sub-districts. There was no CHC in 
two sub-districts. One week (April 11-15) was chosen randomly from 52 weeks (without 
any public holiday) in the year 2011. 
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3.6 DATA MANAGEMENT 
 
3.6.1 VARIABLES 
 
The variables measured for the study are listed in Table 3.1. 
 
Table 3.1 List of variables 
Objectives Variables 
Socio-demographic profile 
 
• Age  
• Gender (Male, female) 
• Ethnicity (Blacks, Whites,  Coloureds, Asians) 
Clinical profile 
 
• Alcohol  history 
• Smoking History  
• Blood pressure 
• Clinical examination  
• Blood glucose 
• Weight 
 
3.6.2 DATA COLLECTION 
 
The data was collected using the NCD tools designed by NDoH (Appendix B). 
 
3.6.3 DATA ANALYSIS 
 
Data was captured with MS Excel software and analysed with NCSS software (NCSS, 
2007). Following descriptive statistics were reported upon. 
• Continuous variables (such as age): Continuous variables with normal distributions: 
mean and standard deviation (SD). Other continuous variables: median and inter-
quartile range.  
• Categorical variables (such as ethnicity): proportion and range. 
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The following analytical statistical tests were used:  
• Continuous variables: t-test and ANOVA 
• Categorical variables: Chi-square test 
• The association among the variables were measured with tests for correlation 
(Pearson or Spearman). 
The statistical significance was calculated at the 95% confidence level.   
 
3.7 ETHICAL CONSIDERATIONS 
 
Permission for conducting research and accessing documents was provided by Head of 
Department for the Gauteng Department of Health and Social Development delegated 
representative (Appendix A). The study was also approved by University of the 
Witwatersrand Human Research Ethics Committee (Medical) (Appendix A). 
Confidentiality and anonymity was maintained all the time for collection, capturing, and 
reporting of the information. Patients’ names and identifications were excluded while 
capturing data and separate study ID was generated for each patient.  
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CHAPTER 4 
RESULTS 
 
The results obtained from the analysis of data are described in this chapter. 
 
4.1 STUDY PARTICIPANTS  
 
Figure 4.1 shows that Zola CHC saw more selected NCD cases which is 35.9% of 968 of 
study participants among the five CHCs.  
 
 
Figure 4.1 Study participants (n = 968) 
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The number of study participants was profiled according to the selected types of NCD as 
listed in Table 4.1. The proportion of study participants with diabetes mellitus was 
39.4%; those with hypertension at 94.6% and the ones with hyper-cholesterolaemia 
were 4.6% of the total 969 participants. 
 
Table 4.1 Number of study participants per disease 
Sites N Diabetes Hypertension Hyper-
cholesterolaemia 
Chiawelo 156 77 (20.1%) 145 (15.8%) 24 (53.3%) 
Discoverers 124 40 (10.4%) 120 (13.1%) 11 (24.4%) 
Hillbrow 133 15 (3.9%) 132 (14.4%) 5 (11.1%) 
LilianNgoyi 208 88 (23.0%) 198 (21.6%) 1 (2.0%) 
Zola 347 162 (42.4%) 321 (35.0%) 4 (8.8%) 
Total 968  382  916 45 
 
However, a number of study participants had co-morbidities, which is listed in Table 4.2. 
Thirty-one study participants had all three diseases.  
 
Table 4.2 co-morbidity of diseases 
sites N Diabetes Hypertension Hyper-
cholesterolaemia 
Diabetes 382  271 (35.2%) 31 (68.8%) 
Hypertension 916 271 (83.3%)  38 (84.4%) 
Hyper-
cholesterolaemia 
45 31 (9.5%)) 38 (4.9%)  
Total 968 325 768 45 
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4.2 SOCIO-DEMOGRAPHIC PROFILE 
 
The socio-demographic profile of the study participants is described below. As a number 
of study participants had two or more diseases, the total number would not add up to 
968. The profiles of the study participants were described for the entire cohort followed 
by categorisation according to three disease cohorts (diabetes, hypertension and 
hypercholesterolemia). For example, diabetic group would include diabetic study 
participants with or without hypertension and hypercholesterolemia or both.  
 
4.2.1 AGE DISTRIBUTION 
 
The mean age of the study participants was 59 years (standard deviation 12 years) with 
the age of youngest and oldest study participants were 19 and 96 years respectively 
(Table 4.3 and Figure 4.2).  
 
Table 4.3 Age distribution of three disease cohorts 
Age (years) n Mean  ± SD  
(in years) 
Diabetes 382 60 ± 11 
Hypertension 916 59 ± 12 
Hyper-cholesterolaemia  45 60± 10 
Total 968 59 ± 12 
SD: standard deviation 
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Figure 4.2 Age distribution of study participants 
 
Age is categorised into four categories: less than 44 years, 44-54 years, 55-63 years and 
more than 64 years (Table 4.4). The majority of the study participants were 45 years and 
above.  
 
Table 4.4 Age distribution 
Age categories N (%) 
Less than 45 years 120 (12.4%) 
45-54 years 268 (27.7%) 
55 – 64 years 298 (30.8%) 
More than 65 years 282 (29.2%) 
Total 968 (100%) 
 
4.2.2 GENDER DISTRIBUTION 
 
The distribution of gender of the study participants is listed in Table 4.5. The prevalence 
of both hypertension and diabetes mellitus was more common in females than males. 
0.0
50.0
100.0
150.0
200.0
20.0 40.0 60.0 80.0 100.0
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Table 4.5 Gender 
  Total Female Male 
Diabetes 382 
 
254 (67%) 128 (33%) 
Hypertension 914 
 
633(69%) 281 (31%) 
Hyper-
cholesterolemia 
45 
 
24(53%) 21 (47%) 
 
There was a significant difference between male and female (chi- square test) in terms 
of prevalence of diabetes (p<0.001) and hyper-cholesterolemia (p=0.03). 
 
4.2.3 ETHNICITY 
 
There were more study participants from Black community than from other race groups 
in the study cohort (Table 4.6). There were no white or Asian population in the hyper-
cholesterolaemia Group. Fisher’s Exact test showed no significant differences between 
the two ethnic groups in terms of prevalence of diabetes and hypertension (p = 0.15).   
 
Table 4.6 Ethnicity 
Ethnicity N Diabetes Hypertension Hyper-
cholesterolaemia 
Blacks 890 378 839 41 
Whites 3 0 3 0 
Asians 2 1 2 0 
Coloureds 3 1 3 1 
Total 898* 378 897 42 
*missing values 
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4.3 CLINICAL PROFILE  
 
4.3.1 RISK FACTORS 
 
4.3.1.1 SMOKING 
 
Interestingly, there were more cases of hypertension, diabetes mellitus and cholesterol 
among non-smokers (Table 4.7). However, chi-square test showed no significant 
differences between the two groups in terms of prevalence of diabetes, hypertension 
and hyper-cholesterolaemia (p = 0.90). 
 
Table 4.7 Smoking 
 Total Smoker Non-smoker 
Diabetes 382(100%) 28 (7%) 354 (93%) 
Hypertension 916(100%) 61 (7%) 855 (93%) 
Hyper-
cholesterolaemia 
45 (100%) 4 (9%) 41 (91%) 
 
4.3.1.2 ALCOHOL 
 
Non-alcohol drinkers were more in numbers across the three selected NCD than alcohol 
drinkers (Table 4.8). However, chi-square test showed no significant differences 
between the two groups in terms of prevalence of diabetes, hypertension and hyper-
cholesterolaemia (p = 0.50). 
 
Table 4.8 Alcohol 
 Total Alcohol Drinker Non-alcohol drinker 
Diabetes 382 (100%) 3 (9%) 346 (91%) 
Hypertension 916 (100%) 103 (11%) 813 (89%) 
Hypercholesterolemia 45 (100%) 11 (24%) 34 (76%) 
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4.3.2 COMPLICATIONS 
 
The complications of NCD are described in Table 4.9. Nephropathy was the most 
common complications followed by cardiac diseases.  
 
Table 4.9 Complications 
CONDITIONS Percentage 
Renal diseases  
Chronic Renal Failure 15 (1.5%) 
Albuminuria 51 (5.2%) 
Elevated Creatinine level 11 (1.1%) 
Cardiac diseases  
Coronary Heart Disease 11 (1.1%) 
Heart Failure 13 (1.3%) 
Peripheral Arterial Disease 5 (0.5%) 
CVA / TIA 14 (1.4%) 
Left Ventricular Hypertrophy 36 (3.7%) 
Advance Retinopathy 7 (0.7%) 
 
4.3.3 SCREENING 
 
There were three types of screening done as per Table 4.10 to identify co-morbid 
conditions: (a) female: cervical screening and breast examination and (b) male: Prostate 
specific antigen.  
 
Table 4.10 Screening 
SCREENING N 
Cervical Screening 189 /657 (28.7%) 
Breast Exam 227 /657 (34.5%) 
Prostate specific antigen 106/309 (34.3%) 
 - 26 -
4.3.4 ANNUAL EXAMINATIONS 
 
A number of annual examinations were done for the 968 study participants (Table 4.11).  
 
Table 4.11 Annual examinations 
ANNUAL EXAMINATION Number and (%)  
Total Cholesterol 164 (16.9%) 
High Density Lipoprotein (HDL) 75 (7.7%) 
Triglycerides 134 (13.8%) 
Low Density Lipoprotein (LDL) 96 (9.9%) 
HBA1C 100 (10.3%) 
Creatinine 100 (10.3%) 
Electro Cardio Gram (ECG) 45 (4.6%) 
Fundoscopy 129 (13.3%) 
Urine Protein 135 (13.9%) 
Urine Test 384 (39.6%) 
Foot Exam 605 (62.5%) 
Oedema 152 (15.7%) 
Peak Flow 39 (4.0%) 
 
4.3.5 CLINICAL EXAMINATIONS 
 
The clinical examination of the study participants included measuring blood pressure, 
weight and blood glucose (Table 4.12). 
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Table 4.12 Clinical examinations 
Clinical examinations Minimum Maximum Mean Standard 
deviation 
BP Systolic (mmHg) 100 203 140 18 
BP Diastolic (mmHg) 10 160 85 10 
Weight (kg) 31 164 82 19 
Blood Glucose (mmol/l) 4 33 8 3 
 
Twenty-two percent of 968 study participants had blood pressure of more than 
140/90mmHg.  Twenty percent of study participants had a weight more than 90kg. The 
blood sugar level of 22% study participants was more than 7 mmol/l. 
 
4.3.6 HEALTH EDUCATION 
 
The following health educations were given to the 968 study participants (Table 4.13) 
 
Table 4.13 Health education 
Health education Number and (%) 
Smoking 673 (69.5%) 
Diet 869 (89.7%) 
Exercise 873 (90.1%) 
Alcohol 646 (66.7%) 
Medications/Adherence 707 (73.0%) 
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CHAPTER 5 
DISCUSSIONS 
 
In this chapter, the results obtained from the analysis of the data were discussed and 
compared with those from other published studies. 
 
5.1 INTRODUCTION 
 
A cross sectional study was conducted in an urban health district with a purpose of 
assessing the socio-demographic and clinical profiles of study participants with selected 
NCD. The focus of the study was on (a) distribution of NCD (i.e. main burden); (b) risk 
factors (i.e. age, gender, ethnicity, smoking, alcohol, complication and co-morbidity); (c) 
management of NCD;  and implications for hospital management. This study was 
conducted in Gauteng health facilities during one week of April 2011 (11- 15) April). 
 
5.2 DISTRIBUTION OF NCD OF THE STUDY PARTICIPANTS  
 
The study observed that the selected NCD (i.e. hypertension; diabetes mellitus and 
hyper-cholesterolaemia) were prevalent in all the study sites. Hypertension was the 
main burden among the three selected NCD. This picture could mean that the probable 
factors of the NCD such as (a) underlying socio-economic, cultural, political and 
environmental determinants; (b) common modifiable risk factors; (c) intermediate risk 
factors and (d) main chronic diseases were perhaps neglected by the District. The study 
by Smith (2007) confirms this situation that the district was reported to be experiencing 
challenges of service delivery in the areas of chronic diseases specifically diabetes and 
hypertension which was echoed by Mayosi, et al (2009).  This scenario from the study 
highlights the need to pay attention to NCD as a global diseases threat and allocate 
more resources for management of these conditions in PHC facilities.  
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The analysis from the findings revealed that more cases were seen in the Zola CHC than 
other CHCs. The reasons could be perhaps due to higher population density. According 
to Johannesburg Health Report for financial year 2011/12, there were a higher number 
of follow-up cases on diabetes and hypertension found in the Sub-district D. This is 
where Zola CHC is situated. Due to vastness of Sub-district D, this scenario justifies the 
opening of the new district hospital in Sub-district D (Zola-Jabulani Hospital) to manage 
the existing complications of chronic diseases which might be beyond Zola CHC. 
 
5.3 RISK FACTORS OF STUDY PARTICIPANTS WITH SELECTED NCD 
 
5.3.1 AGE DISTRIBUTION 
 
The findings of this study indicated that study participants over the age of 45 years 
(87%) were more than those that are less than 45 years of age. This means that the 
District Management should make a concerted effort to target this age group as they 
would be more vulnerable to unwanted deaths if these selected NCD are not prioritised 
and controlled. The NCD Alliance (2011) highlighted the importance of health system 
strengthening with focus on integration of NCD management at PHC level. However, the 
findings in this study are inconsistent with the study by Alwan, et al (2010) which stated 
NCD develop at younger ages, and result in premature death.  The problem that arises 
from this inconsistency might be due to younger patients not attending the health 
facilities and remained undiagnosed. The Johannesburg Health District Management 
Team should recognise the emerging threat of NCD amongst the younger population 
and institute targeted screening programme and possible interventions for them.  
 
 
 
 
 
 - 30 -
5.3.2 GENDER  
 
This study found a higher prevalence of selected NCD among male study participants. 
This could be due to high health seeking behaviours among females than males 
(Chinnakali, Mohan, Upadhyay, et al, 2012). The management of JHB Health District 
would probably need to spend more efforts to attract males through concerted 
attempts of promoting and marketing ‘male friendly’ health facilities.  Added to the 
intervention; females need to be motivated to sustain coming to PHC facilities for 
regular assessment for NCD through health education and promotion.   
 
5.3.3 ETHNICITY  
 
The majority of study participants were Blacks. The catchment population of the 
selected CHCs were located in Black Township. However, there was one facility located 
in the suburbs which was part of the study. This outlook of ethnic difference in response 
to the results indicates that Whites, Coloureds and Asians are probably using other 
alternatives to manage their NCD or they go directly to other levels of health care. 
 
5.3.4 SMOKING AND ALCOHOL 
 
Smoking and alcohol are modifiable risk factors that contribute to the commencement 
of NCD. This study found non-smokers and non-alcohol drinkers were also affected by 
the selected NCD, which might be due to under-reporting or other confounding 
variables. Puoane, Tsokeli, Sanders, et al (2008) proposed that successful NCD control 
would require strong effective service approach, health promotion and prevention. For 
modifiable risk factors such smoking and alcohol drinking, the WHO (2010b) recommend 
the multi-pronged approaches to prevent and alter these as interventions. It is therefore 
necessary that Johannesburg Health District should adopt the WHO STEPwise 
Framework for NCD Risk Factor Surveillance in order to source funds for current and 
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future NCD needs. 
 
5.3.5 CO-MORBIDITY 
 
This study found high prevalence of co-morbid conditions. This indicates that district 
should offer integrated chronic care clinics and may have to plan extra resources 
especially if one patient needs to be treated for many health conditions. Abegunde, et 
al, (2007) highlighted that developing countries health system is functioning at 
maximum capacity and worsening epidemic of NCD is set to further impose strain on an 
already overwhelmed system, which might be the situation in the Johannesburg District. 
   
The most prevalent complications among the study cohort were nephropathy and 
cardiac diseases. This might be due to poor management of these patients and lack of 
integration of NCD in the PHC system. It might be also due to failure of the health 
professionals to check co-morbidities problems. Clinical examination by health 
professionals is an essential component for management and prevention of 
complications (Steyn, Levitt, Patel, et al, 2008). Moodley and Rambiritch (2007) 
suggested better management of NCD would require continuous professional 
development and an up to date knowledge of health professionals about the 
management of NCD.  
 
5.4 MANAGEMENT OF NCD  
 
5.4.1 CLINICAL EXAMINATIONS 
 
Almost 20% of the study participants had poorly controlled hypertension (blood 
pressure of more than 140/90 mm Hg), obesity (weight more than 90kg) and diabetes 
(Blood sugar level more than 7mmol/l). This is of concern and the District management 
should organise a workshop with all the doctors to improve their clinical management 
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practices. 
 
5.4.2 SCREENING  
 
Screening detects asymptomatic cases. For this study, screening focused on cancer 
problems such as female cervical cancer screening, breast cancer screening and prostate 
specific antigen cancer screening. Few screening tests were reported in this study. This 
was probably due to lack of agreed tools for screening and interest in early detection of 
co-morbid conditions. For an example if facilities to conduct mammograms are not 
available in PHC facilities, it would not be done.   
 
5.4.3 ANNUAL EXAMINATIONS  
 
This study found a low uptake of annual examination for NCD study participants. The 
WHO STEPwise Framework for NCD Risk Factor Surveillance assists to identify current 
and future public health needs within the sphere of chronic care. The pinnacle of this 
framework enhances the essential surveillance of physical and bio-chemical 
measurements in the management of risk factors (Bonita, De Court, Dwyer, 2001). 
Regular annual examination is a key to that process. However, the findings of study 
indicated that annual examinations were less prioritised. This means that the district is 
putting minimal efforts to provide examinations of potential risk factors for NCD.  
 
5.4.4   HEALTH EDUCATION  
 
Health education was given priority in the JHB Health District as more study participants 
received some form of education on NCD management. This study’s finding contradicts 
the findings from other studies which reported failure of health facilities to provide with 
appropriate health education at the health facilities (Moodley and Rambiritch, 2007; 
Mayosi, Flisher, Lallo, et al, 2009). The District is probably doing a good job in providing 
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health education on NCD and this practice need to preserved and effected with every 
patient encounter. 
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CHAPTER 6 
CONCLUSION AND RECOMMENDATIONS 
 
In this chapter, the recommendations obtained from this study were assessed in 
relation to the aims and objectives of the study so that appropriate conclusions can be 
drawn. The limitations of the study are listed. Based on the findings of the study, 
appropriate recommendations and suggestions for future research are included.  
 
6.1 CONCLUSIONS RELATED TO THE AIMS OF THE STUDY 
 
This was a cross-sectional study assessment of selected NCD at five community health 
centres in JHB Health District during one week study period in 2011.  Nine-hundred and 
sixty eight study participants were recruited for the study during this period. 
 
6.1.1 DESCRIPTION OF THE CLINICAL PROFILES OF PATIENTS  
 
Among the study participants, the prevalence of hypertension (94.6%) was highest 
followed by diabetes (39.4%) and hyper-cholesterolaemia (4.6%). A number of subjects 
had comorbidity associated with all three conditions. The complications among the 
study participants include nephropathy, cardiac diseases and retinopathy. Annual 
screening was done for a number of study participants but it was erratically done so that 
all study participants were not screened. More than fifth of the patients had poor 
controlled hypertension (blood pressure of more than 140/90 mm Hg), diabetes (Blood 
sugar level more than 7mmol/l) and obesity (weight more than 90kg).  
 
 
 
 
6.1.2 DESCRIPTION OF THE SOCIO-DEMOGRAPHIC AND CLINICAL PROFILES OF 
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STUDY PARTICIPANTS ATTENDING THESE CHCs 
 
The majority of the study participants were 45 years and above (88%), female (53%), 
and black (98%); There were no significant association between these three conditions 
and risk factors such as smoking and alcohol drinking. 
 
6.2 LIMITATIONS OF THE STUDY 
 
The following limitations were encountered during the study period 
(a) Incomplete data- which was addressed by checking patients’ clinical records.  
(b)        Completing the Integrated Chronic Disease patient form by nursing staff was     
      a major challenge due to time constraints.  
 
6.3 RECOMMENDATIONS 
 
6.3.1 FOLLOW-UP  
 
This study found NCD passport as a useful monitoring tool and should be introduced to 
all the health facilities in a phased manner.  
 
This study highlighted the poor patient management associated with failure to screen, 
ability to handle co-morbidities and to minimize complications of NCD. The District 
Management should address this issue by organising workshops with the clinical staff in 
these facilities and share the findings of this study.   
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6.3.2 FUTURE RESEARCH 
 
The future research recommendation for District Management Team is:  
(a) To conduct similar studies in all health facilities for a longer duration.  
(b) To investigate the referral system within NCD to manage comorbidity and 
complications associated with NCD. 
(c) To investigate cost of managing NCD  
 
6.4 CONCLUSION 
 
This study focussed on socio-demographic and clinical profiles of Johannesburg Health 
District’s selected NCD in five CHCs. Similar study was never conducted in JHB and thus 
its uniqueness to advance the knowledge of NCD in Gauteng Province, Johannesburg 
Health Management and the rest of the world. The areas needing attention include the 
reasons for the rising NCD especially diabetes mellitus and hypertension and the low 
tracking of cholesterol problems. 
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ABSTRACT 
 
Background: The World Health Organization predicts that the deaths related to Non-
Communicable Diseases in Africa will rise by 27% over the next decade. As a 
response to the problem, the National Department of Health in South Africa 
 v
introduced interventions that focussed on implementing health facility based Non-
Communicable Diseases register and a monitoring tool. The Gauteng Department of 
Health in South Africa started introducing the monitoring tool in public health 
facilities since April 2011 in a phased manner. This study used a one week data 
collected in the month of April 2011 in selected health facilities within the 
Johannesburg Health District. 
 
Aim: To describe the socio-demographic and clinical profiles of the study population 
attending the health facilities in Johannesburg Health District. 
 
Methodology: A cross-sectional study design was used for the study. The data was 
collected from the selected Community Health Centres using the monitoring tool 
developed by the National Department of Health. The data were collected for a 
week from randomly selected health facilities in 2011. 
 
Results: Nine-hundred and sixty eight study participants were recruited from the five 
community health centres for the assessment of non-communicable diseases.  
Among the study participants, the prevalence of hypertension (94.6%) was highest 
followed by diabetes (39.4%) and hyper-cholesterolaemia (4.6%). A number of study 
participants had comorbidity associated with all three conditions. The majority of 
them were 45 years and above (88%), female (53%), and black (98%); There were no 
significant association between these three conditions and risk factors such as 
smoking and alcohol drinking. The complications among the study participants 
include nephropathy, cardiac diseases and retinopathy. Annual screening was done 
for a number of study participants but it was erratically done so that all study 
participants were not screened. Twenty-two percent of 968 study participants have 
blood pressure of more than 140/90mmHg.  Twenty percent of study participants 
have a weight more than 90kg. The sugar level of 22% study participants was more 
than 7mmol/l. 
 
Conclusion: The NCD monitoring tool could be used as an effective tool for 
management of NCD in PHC setting like Johannesburg Health District.   
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GLOSSARY OF TERMS 
Assessment refers to the measure of the extent of something and the degree to 
which action or policy is carried out. 
Hypertension patients for follow-up:  Patients are diagnosed, put on treatment and 
regularly visit the health facility to check compliance and control of the hypertension 
(source: DHIS, 2010) 
Hypertension patients on treatment:  Number of clients initiated on hypertension 
treatment for the first time (source: DHIS, 2010) 
Hypertension patients on register: All patients who have controlled or no controlled 
hypertension put on register or some of records. (source: DHIS, 2010) 
Diabetes patients for follow-up: Patients are diagnosed, put on treatment and 
regularly visit the health facility to check compliance and control of the diabetes 
(source: DHIS, 2010) 
Diabetes patients on treatment: Number of clients initiated on diabetes treatment 
for the first time (source: DHIS, 2010) 
Diabetes patients on register: All patients who have controlled or no controlled 
diabetes put on register or some of records. (source: DHIS, 2010) 
Health district is defined as geographic area that is small enough to allow maximal 
involvement of the community so that local health needs are met, but also large 
enough to effect economies of scale (Department of Health, White paper on 
transformation of Health System in South Africa, 1997). 
Selected NCD is hypertension, diabetes, and hypercholesterolemia 
Co-morbidity refers to simultaneous occurrence of two or more diseases. Example of 
 xii
chronic diseases co-morbidity include: (1) the association between chronic 
obstructive pulmonary disease and cancer. (Source: Chronic diseases and their risks 
factors: a global burden) 
Urban is an area that is characterized by higher population density and vast human 
features in comparison to areas surrounding it. 
LIST OF ABBREVIATIONS 
 
AIDS Acquired Immunodeficiency Syndrome 
BMI Body Mass Index 
CHCs Community Health Centres 
DHIS District Health Information System 
HIV Human Immunodeficiency Virus 
JHB Johannesburg 
ID Identity document 
MDG Millennium Developmental Goals 
NCD Non-Communicable Diseases 
NDoH National Department of Health 
NSDA Negotiated Service Delivery Agreement 
PHC Primary Health Care 
NCSS A statistical analysis and graphics software package that outputs 
graphics from spreadsheet, database, and statistical files for use 
with popular word processors and presentation software. 
SEMDSA The Society for Endocrinology, Metabolism and Diabetes of South 
Africa 
SD Standard deviation 
UN United Nations 
WHO World Health Organisation 
WITS University of the Witwatersrand  
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CHAPTER 1 
INTRODUCTION 
 
The purpose of this study was to assess the selected Non-Communicable Diseases in an 
urban health district of South Africa. This introductory chapter will cover the 
background to the study, statement of the problem, its aims and objectives and an 
outline of subsequent chapters. 
 
1.1 BACKGROUND 
 
During the last decade, non-communicable diseases (NCD) had been getting much 
attention due to increasing prevalence, morbidity and mortality associated with them 
not only in developed but also in developing countries. It is estimated that 58% of all 
deaths worldwide were contributed to NCD in 2008 (Alwan, MacLean, Riley, 2010). 
These diseases are generally regarded as disease of the affluent. The WHO predicts that 
the deaths related to NCD in Africa will rise by 27% over the next decade (Alwan, 2008).  
 
Despite the mortality, morbidity and the burden of the NCD, the conditions had eluded 
the health list of priorities. The NCD did not feature in the MDG of the United Nations.  
However, the situation had changed during last few years. In 2010, the United Nations 
General Assembly passed a resolution on its 86th plenary session for prevention and 
control of non-communicable diseases. The Assembly also unanimously adopted a 
resolution by which it decided to convene a high-level meeting on “Prevention and 
control of non-communicable diseases” in September 2011 due to high prevalence of 
NCD in both developed and developing countries (UNO, 2010).  
 
The South African Minister of Health also highlighted the challenges associated with 
high burden of NCD in South Africa at the First Global Conference on Healthy Lifestyles 
and NCD Control held in Moscow in 2011 (Department of Health, 2011). Recently, the 
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NCD cluster within the National Department of Health had introduced a number of 
measures for prevention and control of NCD as well as collected accurate information 
about the burden of NCD in South Africa. This included a NCD register for keeping 
records of NCD patients at the clinic as well as a NCD monitoring tool called NCD 
passport (Appendix B) to record individual patient details. 
 
1.2 JUSTIFICATION FOR THE STUDY 
 
The Gauteng Province has one of the highest burdens of NCD in the country (Gauteng 
Department of Health, 2008). Therefore, the Gauteng Department of Health has decided 
to monitor closely the prevalence and the clinical management of NCD through its five 
districts (namely Ekurhuleni, Johannesburg, Sedibeng, Tshwane and West Rand). As a 
part of that process, the district offices are expected to monitor routinely the DHIS data 
on NCD, which were not often done optimally. In addition, the districts were asked to 
introduce the NCD register and NCD passport (a monitoring tool) as disease 
management tools in the public health facilities. The study sought to describe the socio-
demographic and clinical profiles of the patients attending the health facilities in 
Johannesburg Health District. The three selected NCD (Hypertension, Diabetes and 
Hypercholesterolemia) were chosen based on their common etio-pathology. They are 
also the commonest conditions seen in the public health facilities in South Africa.   
 
The findings from this study would hopefully assist the District Management Team to 
understand the burden of the NCD and the associated clinical management of these 
diseases in the District. 
 
1.3 RESEARCH QUESTION 
 
What are the socio-demographic and clinical profiles of study participants with selected 
NCD attending the health facilities in the Johannesburg Health District? 
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1.4 STUDY OBJECTIVES 
 
1.4.1 BROAD OBJECTIVE 
 
To describe the socio-demographic and clinical profiles of study participants with 
selected NCD attending public health facilities in the Johannesburg Health District during 
the one week period in 2011. 
 
1.4.2 SPECIFIC OBJECTIVES 
 
1. To describe the socio-demographic profile (age, gender and ethnicity) of study 
participants with selected NCD (Diabetes, Hypertension and 
hypercholesterolemia) during one week study period. 
2. To describe the clinical profile (such as type of diseases) of the same study 
participants. 
 
1.5 FOLLOWING CHAPTERS 
 
The background to the research has been outlined and discussed. Subsequently, 
research question and objectives were defined in this first chapter. A brief outline of the 
following chapters is described below.  
 
Chapter Two: Literature Review: The purpose of the literature review is to review 
related literature and to discuss concepts related to socio-demographic and clinical 
profiles of study participants with NCD. 
 
Chapter Three: Research Methodology: The chapter describes the research 
methodology, study design, setting and scope and data management techniques used in 
this study. 
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Chapter Four: Presentation of Results: This chapter deals with an analysis of the data 
collected for this study relating to its aim and objectives. 
 
Chapter Five: Discussion: The findings from the review of the literature are included in 
this chapter with the results obtained from the analysis in order to address the aims and 
objectives of the study. 
 
Chapter Six: Conclusions and Recommendations: The chapter is the last part of the 
report and derives conclusions from the research related to the objectives of this study, 
makes recommendations and highlights the areas for future research in the field of NCD. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 5 - 
CHAPTER 2 
LITERATURE REVIEW 
 
This chapter discusses the appropriate and relevant literature on the socio-demographic 
and clinical profiles of study participants with NCD. In addition to published literature, 
information from various unpublished sources is also reviewed.  
 
2.1 INTRODUCTION 
 
2.1.1 INTERNATIONAL CONTEXT OF NON-COMMUNICABLE DISEASES 
 
In 2008, 58% of all deaths worldwide (approximately 33 million) were related to non-
communicable diseases (Alwan, et al, 2010). The Non-Communicable Disease (NCD) 
more specifically includes cardiovascular disease, diabetes, cancer, and chronic 
respiratory diseases (Abegunde, Mathers, Adam, et al, 2007).  
 
Non-communicable diseases are generally regarded as a disease of the affluent. This 
misconception, is refuted as 80% of total NCD-related deaths occur in low and middle 
income countries (Alwan, et al, 2010). The deaths related to NCD in Africa could rise by 
27% over the next decade (NCD alliance, 2011).The chronicity of NCD results in 
extensive mortality and morbidity. In developing countries, NCD develop at younger 
ages, and result in premature death (Alwan, et al, 2010). The economic burden that 
these diseases impose, on the individual and the health system, cannot be ignored 
(WHO, 2010a).  
 
Despite the mortality and morbidity, and the significant worldwide burden, NCD have 
eluded the public health list of priorities. In 2000, NCD did not feature amongst the eight 
Millennium Development Goals identified by the United Nations. This may have dictated 
the limited funding focussed on it. The Centre for Global Development reported that 
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less than three percent of the US$22 billion spent on health, by international aid 
agencies in lower middle income countries, is spent on NCD (NCD alliance, 2011). 
 
Fortunately, World Leaders in May 2010 resolved to hold a United Nations Summit on 
NCD, which was held in September 2011 in New York. The NCD Alliance Partners have 
taken the lead in ensuring that world leaders commit to specifically identified priorities 
on relevant agenda developed by a participatory effort of stakeholders’ worldwide (NCD 
alliance, 2011). 
 
2.1.2 INTERNATIONAL RECOMMENDED INTERVENTIONS FOR NON-COMMUNICABLE 
DISEASES 
 
In many developing countries the health system is functioning at maximum capacity. A 
worsening epidemic of NCD is set to further impose on an already overwhelmed system 
(Abegunde, et al, 2007). The NCD Alliance, among its many suggestions has highlighted 
the importance of health system strengthening (HSS) with a particular focus on primary 
health care (PHC) addressing the integration of NCD management at this level. The basis 
of successful NCD control relies strongly on effective service approach, health 
promotion and prevention (Puoane, Tsokeli, Sanders, et al, 2008).  
 
NCD have complex aetiologies; social-economic, environmental, cultural, biological 
determinants of health all play a role in the disease development (Figure 2.1). For this 
reason multi-pronged approaches to prevent and alter the modifiable risk factors are 
recommended for interventions (WHO, 2010b) 
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Figure 2.1: Causes of Chronic Diseases 
Source: NCD Alliance, 2011  
 
Disease Control Priorities Project in 2006 listed a set of priority interventions 
identified as cost-effective and affordable to implement in various settings. These 
included supporting and education of populations to increase physical activity, 
improve diets, relevant social marketing and facilitating healthy lifestyle decisions. 
The development of sustainable surveillance systems that monitor weight and 
height, physical activity, and key dietary variables is a key intervention and a focus 
of this study (Jamison, Breman, Measham, et al. 2006).   
 
The WHO STEPwise Framework for NCD Risk Factor Surveillance (Figure 2.2) was 
expected to assist DoH in resource poor settings to identify current and future 
public health needs within the sphere of chronic care. The pinnacle of this 
framework should enhance the essential surveillance of physical and bio-chemical 
measurements in the management of risk factors (Bonita, De Court, Dwyer, 2001).  
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Figure 2.2: World Health Organization STEPwise – Non communicable Diseases Risk 
factors concept 
Source: (Bonita, et al, 2001) 
 
2.2 SOUTH AFRICAN CONTEXT FOR NON-COMMUNICABLE DISEASES 
 
South Africa is contextualised within an epidemiological transition, and endures a 
quadruple burden of disease, with a high prevalence of communicable diseases, 
maternal and child health disorders, injury-related mortality and morbidity and NCD. 
With this in mind, it is not surprising that the importance of NCD prevention and 
management has gone unnoticed (Mayosi, Flisher, Lallo, et al, 2009). This created a 
significant negative on health outcomes in South Africa which was evidenced by data 
from 2004, where one-quarter of all disability-adjusted life years were attributed to 
NCD, more specifically 12% due to cardiovascular diseases, diabetes mellitus, respiratory 
diseases and cancers and in the same year one-fifth of total mortality was related to 
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NCD (National Department of Health, 2010). 
 
The prevalence of NCD is set to increase, as South Africans continue to adopt sedentary 
lifestyles and unhealthy diets; and the life expectancy of HIV and AIDS patients increases 
with the advent of an enhanced Anti-Retroviral Therapy Programme. For this reason, 
Mayosi et al (2003) in the South African Lancet series have echoed the sentiments of the 
NCD Alliance, by calling for attention into health system strengthening to meet the 
increased demand for good quality chronic care. 
 
2.3 NCD PREVALENCE IN THE JOHANNESBURG HEALTH DISTRICT 
 
The data on diabetes and hypertension is routinely collected from all health facilities in 
the Johannesburg District. Three indicators are routinely collected for diabetes and 
hypertension. The District Health Report for 2011/12 showed that more diabetes follow 
up cases were found in the Sub-district D with the least cases in the Sub-district A. The 
proportion of follow up cases to treatment of cases was better in the Sub-district A than 
the Sub-district D (Johannesburg Heath District, 2012). 
 
Table 2.1 Prevalence of Diabetes Mellitus in 7 Sub-districts in Johannesburg 
   
Totals 
Sub-
district 
A 
 Sub-
district 
B 
Sub-
district 
C 
 Sub-
district 
D 
Sub-
district 
E 
 Sub-
district 
F 
Sub-
district 
G 
Diabetes 
follow-up 183,278 3,871 8,970 7,888 85,242 27,897 21,302 28,108 
Diabetes on 
treatment 13,783 1,684 834 433 3,872 1,217 1,499 4,244 
Diabetes 
patients on 
register 86,373 2,011 5,471 12,329 32,858 177 7,219 26,308 
 
The hypertension follow up cases were found to be more in the Sub-district D (Table 
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2.2). The proportion of follow up cases to treatment was low in most of the sub-districts 
(Johannesburg Heath District, 2012). 
 
Table 2.2 Prevalence of hypertension in 7 Sub-districts in Johannesburg 
  
Totals 
Sub-
district 
A 
 Sub-
district 
B 
Sub-
district 
C 
 Sub-
district 
D 
Sub-
district 
E 
 Sub-
district 
F 
Sub-
district 
G 
Hypertension 
on treatment 23,814 1,744 1,959 1,239 4,757 2,073 3,547 8,495 
Hypertension 
follow-up 672,899 27,107 38,448 39,303 314,232 87,359 66,494 99,956 
Hypertensive 
patients on 
register 334,298 8,632 38,382 60,227 104,661 906 34,781 86,709 
 
2.4 SUPPORTIVE POLICY FRAMEWORKS 
 
With anticipation from the UN Summit on NCD, the political context began to change 
and to target strategies that would have NCD prevention and control as an outcome. 
This is essential as the NCD Alliance advocates that governments become accountable 
and measured on their successes in preventing and managing NCD (NCD Alliance, 2011). 
The National Department of Health (NDoH) Medium Term Strategic Plan 2010/11-
2012/13 among its ten priorities has identified “Mass Mobilisation For Better Health” a 
commitment of the health sector to enhance prevention and management  strategies to 
mitigate the  burden of NCD (National Department of Health, 2010a). Various policies 
and guidelines were introduced in South Africa since 2006 to manage the emergence of 
the NCD within the health system. These policies require that all health facilities in 
South Africa are expected to capture data on the prescribed registers or forms of NCD 
patients and to clinically manage all NCD as per guidelines and procedures outlined from 
the policies. The researcher perceives that the burden of NCD is unknown to many 
health care workers and managers and often the policies with guidelines are not being 
implemented. 
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Subsequently, the Negotiated Service Delivery Agreement (NSDA) within the four output 
areas (namely increasing life expectancy, decreasing maternal and child mortality, 
combating HIV and AIDS and decreasing the burden of disease from tuberculosis and 
strengthening health system effectiveness), has spoken to the focus on NCD prevention 
and management, and increased influx of resources. Improved surveillance of chronic 
diseases are required and the identification of innovative technologies in the sector, 
including recruiting and strengthening the capacity of community health workers’ 
involvement in the implementation of the chronic care model (National Department of 
Health, 2010).  
 
Furthermore, National Guidelines published by the NDoH in 2006 , entitled “Non-
Communicable Diseases Strategic Vision” explains the effective management of NCD 
and the integration all chronic diseases in its treatment in a patient-centred approach 
alignment of a formation of health public policy (National Department of Health, 2006). 
Gauteng Department of Health’s strategy has aligned itself with national priority and 
identified prevention and control NCD (Gauteng Department of Health and Social 
Development, 2009). This strategy included other guidelines as per Table 2.3. 
  
Table 2.3 South African National Guidelines on NCD 
Guidelines 
 
Year 
 
National Guidelines on Primary Prevention of Chronic Diseases of 
Lifestyle 
2005 
 
National Guideline: Non-communicable Diseases: A strategic Vision  
 
2006 
 
South African Hypertension Guideline 
 
2011 
 
South African Dyslipidaemia Guideline 
 
2012 
 
SEMDSA Guideline for Management of Type 2 Diabetes 
 
2012 
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With strong leadership and the much needed political focus on NCD as suggested by the 
NCD Alliance (NCD Alliance, 2011), the time is appropriate to enhance the chronic care 
at the District. The Johannesburg Health District was reported to be experiencing 
challenges in service delivery (one of the six building blocks of the Health System) of in 
the areas of chronic diseases specifically diabetes and hypertension (Smith, 2007). 
 
Hence the development of the Integrated Chronic Disease Map could act as a visual aid 
and comprehensive tool to simplify NCD prevention and management. The tool allows 
for risk factor surveillance of both modifiable risk factors (primary prevention), the 
assurance of appropriate control of biochemical markers (secondary prevention), and 
lastly investigations and monitoring of target organ damage (tertiary prevention) in a 
district setting.  
 
2.5 FACTORS INFLUENCING MANAGEMENT OF NCD 
 
Factors influencing management of NCD can be grouped into three main categories 
namely patient related factors, health professional related factors and health system 
related factors.  
 
2.5.1 PATIENT RELATED FACTORS 
 
Patient related factors such as knowledge, culture and beliefs influences people’s 
attitude to health, as well as their health seeking behaviour and control of NCD 
(Baradaran and Knill-Jones, 2004). Patient factors that influence good management of 
NCD (such as diabetes) include compliance, regular attendance, health education, 
younger age and female (Alberti, Boudriga, Nabli, 2007). Although health education 
plays an important role in improving patients’ compliance, patients are often not 
provided with appropriate health education at the health facilities (Moodley and 
Rambiritch, 2007). 
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2.5.2 HEALTH CARE PROFESSIONAL FACTORS 
 
Better management of NCD is based on the continuous professional development and 
an up to date knowledge of health professionals about the management of NCD 
(Moodley and Rambiritch, 2007). Standardisation of care with the use of clinical 
guidelines has been shown to improve patient outcomes (Brown, Harris, Webster-
Bogaert, et al, 2002).  
 
Thorough clinical examination by health professionals is an essential component for 
management and prevention of complications (Steyn, Levitt, Patel, et al, 2008). 
However this requires time and health professionals often compromise that due to 
increased work load as a result of staff shortages. Other health care professional related 
factors identified included numbers of health care staff, their training, health care 
professional motivation (Sutton, McLean, 2006; Simmons, Lillian, Swan, et al, 2007).  
 
2.5.3 HEALTH SYSTEM FACTORS 
 
The clinical management of NCD requires good organisational systems which provide an 
efficient and effective management of resources such as drug, equipment (Brown, et al, 
2002). The availability of innovative tools such as defaulter tracing and reminder 
systems could assist in achieving better control. Other health system related factors 
found to influence NCD care include the presence of dedicated NCD clinics, availability 
of clinical guidelines, and health (Alberti, et al, 2007).   
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CHAPTER 3 
METHODOLOGY 
 
The methodology for this study was selected on the basis of its aims and objectives. In 
this chapter the following were/would be discussed: setting, scope, and study design 
and research tools. 
 
3.1 STUDY DESIGN 
 
This was a cross sectional study conducted in Johannesburg Health District facilities. 
 
3.2 STUDY SETTING 
 
The study setting was Johannesburg Health District, an urban district, located in 
Gauteng Province of South Africa.  
 
Gauteng Province has five health districts namely Johannesburg, Ekurhuleni, Tshwane, 
Sedibeng and West Rand. The sixth District Metsweding was recently merged with the 
Tshwane District. The Gauteng Department of Health provides health services to 8.3 
million people (uninsured) through a network of hospitals; community health centres 
(CHCs), fixed primary health care (PHC) clinics and mobile clinics, as well as community 
outreach programmes.  
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Figure 3.1 Gauteng Province 
 
Source: Annual Performance plan, 2010/2011-2012/13, Gauteng Department of Health 
 
Johannesburg Health District  
 
The Johannesburg Health District is one of the most populated districts in South Africa. 
Comparing the district with other four districts in the Gauteng Province, it has 114 (36%) 
clinics, 10 (29%) community health centres, one district hospital (9%), one specialised 
hospital, one psychiatric hospital, one (17%) regional hospital, one tertiary hospital 
(33%) and two (50%) central hospitals. All the health facilities provide services for 
patients suffering from NCD. According to Statistics South Africa’s community survey, 
the population served by the public health facilities is estimated at 3,888,180 in 2007 
(Statistics South Africa, 2007). 
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3.3 STUDY SCOPE 
 
The study involved analysis of secondary data collected from selected CHCs using the 
NCD monitoring tool (Appendix B) introduced by the NDoH in 2011. 
 
3.4 STUDY PERIOD 
 
The study period was one week chosen randomly from 52 weeks (without any public 
holiday) in the year 2011.  
 
3.5 STUDY POPULATION AND SAMPLING 
 
The study population included NCD patients attending CHCs in JHB Health District. Five 
CHCs were randomly chosen from a total of seven sub-districts. There was no CHC in 
two sub-districts. One week (April 11-15) was chosen randomly from 52 weeks (without 
any public holiday) in the year 2011. 
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3.6 DATA MANAGEMENT 
 
3.6.1 VARIABLES 
 
The variables measured for the study are listed in Table 3.1. 
 
Table 3.1 List of variables 
Objectives Variables 
Socio-demographic profile 
 
• Age  
• Gender (Male, female) 
• Ethnicity (Blacks, Whites,  Coloureds, Asians) 
Clinical profile 
 
• Alcohol  history 
• Smoking History  
• Blood pressure 
• Clinical examination  
• Blood glucose 
• Weight 
 
3.6.2 DATA COLLECTION 
 
The data was collected using the NCD tools designed by NDoH (Appendix B). 
 
3.6.3 DATA ANALYSIS 
 
Data was captured with MS Excel software and analysed with NCSS software (NCSS, 
2007). Following descriptive statistics were reported upon. 
• Continuous variables (such as age): Continuous variables with normal distributions: 
mean and standard deviation (SD). Other continuous variables: median and inter-
quartile range.  
• Categorical variables (such as ethnicity): proportion and range. 
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The following analytical statistical tests were used:  
• Continuous variables: t-test and ANOVA 
• Categorical variables: Chi-square test 
• The association among the variables were measured with tests for correlation 
(Pearson or Spearman). 
The statistical significance was calculated at the 95% confidence level.   
 
3.7 ETHICAL CONSIDERATIONS 
 
Permission for conducting research and accessing documents was provided by Head of 
Department for the Gauteng Department of Health and Social Development delegated 
representative (Appendix A). The study was also approved by University of the 
Witwatersrand Human Research Ethics Committee (Medical) (Appendix A). 
Confidentiality and anonymity was maintained all the time for collection, capturing, and 
reporting of the information. Patients’ names and identifications were excluded while 
capturing data and separate study ID was generated for each patient.  
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CHAPTER 4 
RESULTS 
 
The results obtained from the analysis of data are described in this chapter. 
 
4.1 STUDY PARTICIPANTS  
 
Figure 4.1 shows that Zola CHC saw more selected NCD cases which is 35.9% of 968 of 
study participants among the five CHCs.  
 
 
Figure 4.1 Study participants (n = 968) 
 
 
 - 20 -
 
The number of study participants was profiled according to the selected types of NCD as 
listed in Table 4.1. The proportion of study participants with diabetes mellitus was 
39.4%; those with hypertension at 94.6% and the ones with hyper-cholesterolaemia 
were 4.6% of the total 969 participants. 
 
Table 4.1 Number of study participants per disease 
Sites N Diabetes Hypertension Hyper-
cholesterolaemia 
Chiawelo 156 77 (20.1%) 145 (15.8%) 24 (53.3%) 
Discoverers 124 40 (10.4%) 120 (13.1%) 11 (24.4%) 
Hillbrow 133 15 (3.9%) 132 (14.4%) 5 (11.1%) 
LilianNgoyi 208 88 (23.0%) 198 (21.6%) 1 (2.0%) 
Zola 347 162 (42.4%) 321 (35.0%) 4 (8.8%) 
Total 968  382  916 45 
 
However, a number of study participants had co-morbidities, which is listed in Table 4.2. 
Thirty-one study participants had all three diseases.  
 
Table 4.2 co-morbidity of diseases 
sites N Diabetes Hypertension Hyper-
cholesterolaemia 
Diabetes 382  271 (35.2%) 31 (68.8%) 
Hypertension 916 271 (83.3%)  38 (84.4%) 
Hyper-
cholesterolaemia 
45 31 (9.5%)) 38 (4.9%)  
Total 968 325 768 45 
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4.2 SOCIO-DEMOGRAPHIC PROFILE 
 
The socio-demographic profile of the study participants is described below. As a number 
of study participants had two or more diseases, the total number would not add up to 
968. The profiles of the study participants were described for the entire cohort followed 
by categorisation according to three disease cohorts (diabetes, hypertension and 
hypercholesterolemia). For example, diabetic group would include diabetic study 
participants with or without hypertension and hypercholesterolemia or both.  
 
4.2.1 AGE DISTRIBUTION 
 
The mean age of the study participants was 59 years (standard deviation 12 years) with 
the age of youngest and oldest study participants were 19 and 96 years respectively 
(Table 4.3 and Figure 4.2).  
 
Table 4.3 Age distribution of three disease cohorts 
Age (years) n Mean  ± SD  
(in years) 
Diabetes 382 60 ± 11 
Hypertension 916 59 ± 12 
Hyper-cholesterolaemia  45 60± 10 
Total 968 59 ± 12 
SD: standard deviation 
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Figure 4.2 Age distribution of study participants 
 
Age is categorised into four categories: less than 44 years, 44-54 years, 55-63 years and 
more than 64 years (Table 4.4). The majority of the study participants were 45 years and 
above.  
 
Table 4.4 Age distribution 
Age categories N (%) 
Less than 45 years 120 (12.4%) 
45-54 years 268 (27.7%) 
55 – 64 years 298 (30.8%) 
More than 65 years 282 (29.2%) 
Total 968 (100%) 
 
4.2.2 GENDER DISTRIBUTION 
 
The distribution of gender of the study participants is listed in Table 4.5. The prevalence 
of both hypertension and diabetes mellitus was more common in females than males. 
0.0
50.0
100.0
150.0
200.0
20.0 40.0 60.0 80.0 100.0
age (years)
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Table 4.5 Gender 
  Total Female Male 
Diabetes 382 
 
254 (67%) 128 (33%) 
Hypertension 914 
 
633(69%) 281 (31%) 
Hyper-
cholesterolemia 
45 
 
24(53%) 21 (47%) 
 
There was a significant difference between male and female (chi- square test) in terms 
of prevalence of diabetes (p<0.001) and hyper-cholesterolemia (p=0.03). 
 
4.2.3 ETHNICITY 
 
There were more study participants from Black community than from other race groups 
in the study cohort (Table 4.6). There were no white or Asian population in the hyper-
cholesterolaemia Group. Fisher’s Exact test showed no significant differences between 
the two ethnic groups in terms of prevalence of diabetes and hypertension (p = 0.15).   
 
Table 4.6 Ethnicity 
Ethnicity N Diabetes Hypertension Hyper-
cholesterolaemia 
Blacks 890 378 839 41 
Whites 3 0 3 0 
Asians 2 1 2 0 
Coloureds 3 1 3 1 
Total 898* 378 897 42 
*missing values 
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4.3 CLINICAL PROFILE  
 
4.3.1 RISK FACTORS 
 
4.3.1.1 SMOKING 
 
Interestingly, there were more cases of hypertension, diabetes mellitus and cholesterol 
among non-smokers (Table 4.7). However, chi-square test showed no significant 
differences between the two groups in terms of prevalence of diabetes, hypertension 
and hyper-cholesterolaemia (p = 0.90). 
 
Table 4.7 Smoking 
 Total Smoker Non-smoker 
Diabetes 382(100%) 28 (7%) 354 (93%) 
Hypertension 916(100%) 61 (7%) 855 (93%) 
Hyper-
cholesterolaemia 
45 (100%) 4 (9%) 41 (91%) 
 
4.3.1.2 ALCOHOL 
 
Non-alcohol drinkers were more in numbers across the three selected NCD than alcohol 
drinkers (Table 4.8). However, chi-square test showed no significant differences 
between the two groups in terms of prevalence of diabetes, hypertension and hyper-
cholesterolaemia (p = 0.50). 
 
Table 4.8 Alcohol 
 Total Alcohol Drinker Non-alcohol drinker 
Diabetes 382 (100%) 3 (9%) 346 (91%) 
Hypertension 916 (100%) 103 (11%) 813 (89%) 
Hypercholesterolemia 45 (100%) 11 (24%) 34 (76%) 
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4.3.2 COMPLICATIONS 
 
The complications of NCD are described in Table 4.9. Nephropathy was the most 
common complications followed by cardiac diseases.  
 
Table 4.9 Complications 
CONDITIONS Percentage 
Renal diseases  
Chronic Renal Failure 15 (1.5%) 
Albuminuria 51 (5.2%) 
Elevated Creatinine level 11 (1.1%) 
Cardiac diseases  
Coronary Heart Disease 11 (1.1%) 
Heart Failure 13 (1.3%) 
Peripheral Arterial Disease 5 (0.5%) 
CVA / TIA 14 (1.4%) 
Left Ventricular Hypertrophy 36 (3.7%) 
Advance Retinopathy 7 (0.7%) 
 
4.3.3 SCREENING 
 
There were three types of screening done as per Table 4.10 to identify co-morbid 
conditions: (a) female: cervical screening and breast examination and (b) male: Prostate 
specific antigen.  
 
Table 4.10 Screening 
SCREENING N 
Cervical Screening 189 /657 (28.7%) 
Breast Exam 227 /657 (34.5%) 
Prostate specific antigen 106/309 (34.3%) 
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4.3.4 ANNUAL EXAMINATIONS 
 
A number of annual examinations were done for the 968 study participants (Table 4.11).  
 
Table 4.11 Annual examinations 
ANNUAL EXAMINATION Number and (%)  
Total Cholesterol 164 (16.9%) 
High Density Lipoprotein (HDL) 75 (7.7%) 
Triglycerides 134 (13.8%) 
Low Density Lipoprotein (LDL) 96 (9.9%) 
HBA1C 100 (10.3%) 
Creatinine 100 (10.3%) 
Electro Cardio Gram (ECG) 45 (4.6%) 
Fundoscopy 129 (13.3%) 
Urine Protein 135 (13.9%) 
Urine Test 384 (39.6%) 
Foot Exam 605 (62.5%) 
Oedema 152 (15.7%) 
Peak Flow 39 (4.0%) 
 
4.3.5 CLINICAL EXAMINATIONS 
 
The clinical examination of the study participants included measuring blood pressure, 
weight and blood glucose (Table 4.12). 
 
 
 
 
 
 
 - 27 -
Table 4.12 Clinical examinations 
Clinical examinations Minimum Maximum Mean Standard 
deviation 
BP Systolic (mmHg) 100 203 140 18 
BP Diastolic (mmHg) 10 160 85 10 
Weight (kg) 31 164 82 19 
Blood Glucose (mmol/l) 4 33 8 3 
 
Twenty-two percent of 968 study participants had blood pressure of more than 
140/90mmHg.  Twenty percent of study participants had a weight more than 90kg. The 
blood sugar level of 22% study participants was more than 7 mmol/l. 
 
4.3.6 HEALTH EDUCATION 
 
The following health educations were given to the 968 study participants (Table 4.13) 
 
Table 4.13 Health education 
Health education Number and (%) 
Smoking 673 (69.5%) 
Diet 869 (89.7%) 
Exercise 873 (90.1%) 
Alcohol 646 (66.7%) 
Medications/Adherence 707 (73.0%) 
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CHAPTER 5 
DISCUSSIONS 
 
In this chapter, the results obtained from the analysis of the data were discussed and 
compared with those from other published studies. 
 
5.1 INTRODUCTION 
 
A cross sectional study was conducted in an urban health district with a purpose of 
assessing the socio-demographic and clinical profiles of study participants with selected 
NCD. The focus of the study was on (a) distribution of NCD (i.e. main burden); (b) risk 
factors (i.e. age, gender, ethnicity, smoking, alcohol, complication and co-morbidity); (c) 
management of NCD;  and implications for hospital management. This study was 
conducted in Gauteng health facilities during one week of April 2011 (11- 15) April). 
 
5.2 DISTRIBUTION OF NCD OF THE STUDY PARTICIPANTS  
 
The study observed that the selected NCD (i.e. hypertension; diabetes mellitus and 
hyper-cholesterolaemia) were prevalent in all the study sites. Hypertension was the 
main burden among the three selected NCD. This picture could mean that the probable 
factors of the NCD such as (a) underlying socio-economic, cultural, political and 
environmental determinants; (b) common modifiable risk factors; (c) intermediate risk 
factors and (d) main chronic diseases were perhaps neglected by the District. The study 
by Smith (2007) confirms this situation that the district was reported to be experiencing 
challenges of service delivery in the areas of chronic diseases specifically diabetes and 
hypertension which was echoed by Mayosi, et al (2009).  This scenario from the study 
highlights the need to pay attention to NCD as a global diseases threat and allocate 
more resources for management of these conditions in PHC facilities.  
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The analysis from the findings revealed that more cases were seen in the Zola CHC than 
other CHCs. The reasons could be perhaps due to higher population density. According 
to Johannesburg Health Report for financial year 2011/12, there were a higher number 
of follow-up cases on diabetes and hypertension found in the Sub-district D. This is 
where Zola CHC is situated. Due to vastness of Sub-district D, this scenario justifies the 
opening of the new district hospital in Sub-district D (Zola-Jabulani Hospital) to manage 
the existing complications of chronic diseases which might be beyond Zola CHC. 
 
5.3 RISK FACTORS OF STUDY PARTICIPANTS WITH SELECTED NCD 
 
5.3.1 AGE DISTRIBUTION 
 
The findings of this study indicated that study participants over the age of 45 years 
(87%) were more than those that are less than 45 years of age. This means that the 
District Management should make a concerted effort to target this age group as they 
would be more vulnerable to unwanted deaths if these selected NCD are not prioritised 
and controlled. The NCD Alliance (2011) highlighted the importance of health system 
strengthening with focus on integration of NCD management at PHC level. However, the 
findings in this study are inconsistent with the study by Alwan, et al (2010) which stated 
NCD develop at younger ages, and result in premature death.  The problem that arises 
from this inconsistency might be due to younger patients not attending the health 
facilities and remained undiagnosed. The Johannesburg Health District Management 
Team should recognise the emerging threat of NCD amongst the younger population 
and institute targeted screening programme and possible interventions for them.  
 
 
 
 
 
 - 30 -
5.3.2 GENDER  
 
This study found a higher prevalence of selected NCD among male study participants. 
This could be due to high health seeking behaviours among females than males 
(Chinnakali, Mohan, Upadhyay, et al, 2012). The management of JHB Health District 
would probably need to spend more efforts to attract males through concerted 
attempts of promoting and marketing ‘male friendly’ health facilities.  Added to the 
intervention; females need to be motivated to sustain coming to PHC facilities for 
regular assessment for NCD through health education and promotion.   
 
5.3.3 ETHNICITY  
 
The majority of study participants were Blacks. The catchment population of the 
selected CHCs were located in Black Township. However, there was one facility located 
in the suburbs which was part of the study. This outlook of ethnic difference in response 
to the results indicates that Whites, Coloureds and Asians are probably using other 
alternatives to manage their NCD or they go directly to other levels of health care. 
 
5.3.4 SMOKING AND ALCOHOL 
 
Smoking and alcohol are modifiable risk factors that contribute to the commencement 
of NCD. This study found non-smokers and non-alcohol drinkers were also affected by 
the selected NCD, which might be due to under-reporting or other confounding 
variables. Puoane, Tsokeli, Sanders, et al (2008) proposed that successful NCD control 
would require strong effective service approach, health promotion and prevention. For 
modifiable risk factors such smoking and alcohol drinking, the WHO (2010b) recommend 
the multi-pronged approaches to prevent and alter these as interventions. It is therefore 
necessary that Johannesburg Health District should adopt the WHO STEPwise 
Framework for NCD Risk Factor Surveillance in order to source funds for current and 
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future NCD needs. 
 
5.3.5 CO-MORBIDITY 
 
This study found high prevalence of co-morbid conditions. This indicates that district 
should offer integrated chronic care clinics and may have to plan extra resources 
especially if one patient needs to be treated for many health conditions. Abegunde, et 
al, (2007) highlighted that developing countries health system is functioning at 
maximum capacity and worsening epidemic of NCD is set to further impose strain on an 
already overwhelmed system, which might be the situation in the Johannesburg District. 
   
The most prevalent complications among the study cohort were nephropathy and 
cardiac diseases. This might be due to poor management of these patients and lack of 
integration of NCD in the PHC system. It might be also due to failure of the health 
professionals to check co-morbidities problems. Clinical examination by health 
professionals is an essential component for management and prevention of 
complications (Steyn, Levitt, Patel, et al, 2008). Moodley and Rambiritch (2007) 
suggested better management of NCD would require continuous professional 
development and an up to date knowledge of health professionals about the 
management of NCD.  
 
5.4 MANAGEMENT OF NCD  
 
5.4.1 CLINICAL EXAMINATIONS 
 
Almost 20% of the study participants had poorly controlled hypertension (blood 
pressure of more than 140/90 mm Hg), obesity (weight more than 90kg) and diabetes 
(Blood sugar level more than 7mmol/l). This is of concern and the District management 
should organise a workshop with all the doctors to improve their clinical management 
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practices. 
 
5.4.2 SCREENING  
 
Screening detects asymptomatic cases. For this study, screening focused on cancer 
problems such as female cervical cancer screening, breast cancer screening and prostate 
specific antigen cancer screening. Few screening tests were reported in this study. This 
was probably due to lack of agreed tools for screening and interest in early detection of 
co-morbid conditions. For an example if facilities to conduct mammograms are not 
available in PHC facilities, it would not be done.   
 
5.4.3 ANNUAL EXAMINATIONS  
 
This study found a low uptake of annual examination for NCD study participants. The 
WHO STEPwise Framework for NCD Risk Factor Surveillance assists to identify current 
and future public health needs within the sphere of chronic care. The pinnacle of this 
framework enhances the essential surveillance of physical and bio-chemical 
measurements in the management of risk factors (Bonita, De Court, Dwyer, 2001). 
Regular annual examination is a key to that process. However, the findings of study 
indicated that annual examinations were less prioritised. This means that the district is 
putting minimal efforts to provide examinations of potential risk factors for NCD.  
 
5.4.4   HEALTH EDUCATION  
 
Health education was given priority in the JHB Health District as more study participants 
received some form of education on NCD management. This study’s finding contradicts 
the findings from other studies which reported failure of health facilities to provide with 
appropriate health education at the health facilities (Moodley and Rambiritch, 2007; 
Mayosi, Flisher, Lallo, et al, 2009). The District is probably doing a good job in providing 
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health education on NCD and this practice need to preserved and effected with every 
patient encounter. 
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CHAPTER 6 
CONCLUSION AND RECOMMENDATIONS 
 
In this chapter, the recommendations obtained from this study were assessed in 
relation to the aims and objectives of the study so that appropriate conclusions can be 
drawn. The limitations of the study are listed. Based on the findings of the study, 
appropriate recommendations and suggestions for future research are included.  
 
6.1 CONCLUSIONS RELATED TO THE AIMS OF THE STUDY 
 
This was a cross-sectional study assessment of selected NCD at five community health 
centres in JHB Health District during one week study period in 2011.  Nine-hundred and 
sixty eight study participants were recruited for the study during this period. 
 
6.1.1 DESCRIPTION OF THE CLINICAL PROFILES OF PATIENTS  
 
Among the study participants, the prevalence of hypertension (94.6%) was highest 
followed by diabetes (39.4%) and hyper-cholesterolaemia (4.6%). A number of subjects 
had comorbidity associated with all three conditions. The complications among the 
study participants include nephropathy, cardiac diseases and retinopathy. Annual 
screening was done for a number of study participants but it was erratically done so that 
all study participants were not screened. More than fifth of the patients had poor 
controlled hypertension (blood pressure of more than 140/90 mm Hg), diabetes (Blood 
sugar level more than 7mmol/l) and obesity (weight more than 90kg).  
 
 
 
 
6.1.2 DESCRIPTION OF THE SOCIO-DEMOGRAPHIC AND CLINICAL PROFILES OF 
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STUDY PARTICIPANTS ATTENDING THESE CHCs 
 
The majority of the study participants were 45 years and above (88%), female (53%), 
and black (98%); There were no significant association between these three conditions 
and risk factors such as smoking and alcohol drinking. 
 
6.2 LIMITATIONS OF THE STUDY 
 
The following limitations were encountered during the study period 
(a) Incomplete data- which was addressed by checking patients’ clinical records.  
(b)        Completing the Integrated Chronic Disease patient form by nursing staff was     
      a major challenge due to time constraints.  
 
6.3 RECOMMENDATIONS 
 
6.3.1 FOLLOW-UP  
 
This study found NCD passport as a useful monitoring tool and should be introduced to 
all the health facilities in a phased manner.  
 
This study highlighted the poor patient management associated with failure to screen, 
ability to handle co-morbidities and to minimize complications of NCD. The District 
Management should address this issue by organising workshops with the clinical staff in 
these facilities and share the findings of this study.   
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6.3.2 FUTURE RESEARCH 
 
The future research recommendation for District Management Team is:  
(a) To conduct similar studies in all health facilities for a longer duration.  
(b) To investigate the referral system within NCD to manage comorbidity and 
complications associated with NCD. 
(c) To investigate cost of managing NCD  
 
6.4 CONCLUSION 
 
This study focussed on socio-demographic and clinical profiles of Johannesburg Health 
District’s selected NCD in five CHCs. Similar study was never conducted in JHB and thus 
its uniqueness to advance the knowledge of NCD in Gauteng Province, Johannesburg 
Health Management and the rest of the world. The areas needing attention include the 
reasons for the rising NCD especially diabetes mellitus and hypertension and the low 
tracking of cholesterol problems. 
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